ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sensorion

Sensorion (ALSEN)

0.686
0.00
(0.00%)
Closed July 11 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.686
Bid
0.684
Ask
0.70
Volume
0.00
0.00 Day's Range 0.00
0.3105 52 Week Range 1.04
Market Cap
Previous Close
0.686
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
36,984
Shares Outstanding
300,250,225
Dividend Yield
-
PE Ratio
-37.14
Earnings Per Share (EPS)
-0.07
Revenue
5.7M
Net Profit
-22.06M

About Sensorion

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Montpellier, Herault, Fra
Founded
1970
Sensorion is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALSEN. The last closing price for Sensorion was 0.69 €. Over the last year, Sensorion shares have traded in a share price range of 0.3105 € to 1.04 €.

Sensorion currently has 300,250,225 shares outstanding. The market capitalization of Sensorion is 205.97 € million. Sensorion has a price to earnings ratio (PE ratio) of -37.14.

ALSEN Latest News

Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...

Sensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies Implantables

Regulatory News: Sensorion (FR0012596468 – ALSEN), société de biotechnologie pionnière au stade clinique spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...

Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...

Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024

Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...

Sensorion met à disposition des documents préparatoires à l’Assemblée générale mixte du 29 mai 2024

Regulatory News: Sensorion (FR0012596468 - ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...

Sensorion annonce sa participation à la conférence annuelle de la Société Américaine de Thérapie Génique et Cellulaire (ASGCT)

Regulatory News: Sensorion (FR0012596468 - ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...

Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...

Sensorion annonce un financement de 15 millions d’euros, et étend son horizon de trésorerie jusqu’à la fin de l’année 2025

Soutien des investisseurs existants, dont notamment Redmile Group, Invus, Sofinnova Partners et d’une société importante de gestion de placements Le financement permettra à la Société d'étendre...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0060.8823529411760.680.710.68187640.68923873DE
4-0.054-7.29729729730.740.7640.57430020.67112645DE
12-0.016-2.27920227920.7020.850.57369840.72086441DE
260.18637.20.51.040.461825070.75545826DE
520.346101.7647058820.341.040.3105871180.65791644DE
156-1.112-61.84649610681.7982.290.26812660.81365192DE
260-0.874-56.02564102561.562.880.26896491.1302112DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
IVPInspire Veterinary Partners Inc
$ 8.11
(130.40%)
29.26M
NBSTWNewbury Street Acquisition Corporation
$ 0.0998
(66.33%)
3.1k
CYCNCyclerion Therapeutics Inc
$ 3.81
(65.64%)
18.89k
CINGCingulate Inc
$ 0.5996
(61.05%)
1.24M
ZAPPZapp Electric Vehicles Group Ltd
$ 9.40
(-47.63%)
9.97M
SISIShineco Inc
$ 2.49
(-44.79%)
1.59M
CVRXCVRx Inc
$ 7.18
(-38.26%)
2.04M
ICUSeaStar Medical Holding Corporation
$ 8.07
(-37.92%)
1.12M
TOIIWOncology Institute Inc
$ 0.0185
(-31.23%)
2.57k
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
NVDANVIDIA Corporation
$ 134.91
(2.69%)
248.96M
MAXNMaxeon Solar Technologies Ltd
$ 0.2078
(-16.21%)
246.5M
TSLATesla Inc
$ 263.26
(0.35%)
128.52M
VRPXVirpax Pharmaceuticals Inc
$ 1.68
(44.83%)
117.18M

Discussion

View Full Feed
janice shell janice shell 40 seconds ago
OH! You're so nieve!

So what? If you're going to accuse others here of being naive, you'd better learn to spell it correctly.
doc063 doc063 6 minutes ago
I'm seeing all of the attention on RNVA and not FOXO on IHub.

Something to make us all think about what's cooking in the background.
FOXO RNVA
somberfox somberfox 6 minutes ago
Nah man, we're gonna get a watch, you know, the thing that's never used in 2024, save for Garmins/fitbits.
RONN
Lazarus Lazarus 7 minutes ago
Just dropped in to make sure you're still holdin' down the fort here.

This from the book of Ecclesiasticus [chapter 38]:

Honour a physician with the honour due unto him for the uses which ye may have of him: for the Lord hath created him.

For of the most
chereb19 chereb19 7 minutes ago
Direct Interstitial Injection: An Approach to Optimizing Therapeutic Ratios for Safe and Effective Delivery of High-dose Radionuclide Therapy in Treating Solid Tumors (P446)
Mon, July 08
Gatlin C/D
Poster Session

Part of:
Poster Session 1
Info
RDGL
LetGoodTimesRoll LetGoodTimesRoll 9 minutes ago
$RNVA==>$FOXO ===>NYSE====>$$$$$$$
FOXO RNVA
GoodGuyBill GoodGuyBill 9 minutes ago
And your comment... ROTFLMAO!!!!

Your entire comment is simply no more than a speculative wish list, akin to a child writing to santa, in the hope of getting a new bike 🚲 ☝️🥴
NWBO
Lazarus Lazarus 12 minutes ago
oops / duplicate
Lazarus Lazarus 12 minutes ago
My late brother had a RX filled incorrectly and I think he had a bad reaction. I'm not sure who his attorney sued - doctor or pharmacist - but he got something like $30k as a result. This was around 45 years ago
Vexari Vexari 13 minutes ago
The cartel

Has no remorse
janice shell janice shell 13 minutes ago
Does anyone know what really happened during Donald Trumps trial?

You really are a dimwit. A dimwit without a television, it seems. All the networks had people in the courtroom transcribing what happened at the trial. And yes, there was an official steno, who produced official transcr
littlejohn littlejohn 14 minutes ago
TSLA - China - bicycles - rising EV sales

by China companies in 2024 are

still putting margin pressure on TSLA...

Bicycles are still owned by most China

folks in case the power goes out,

so the EVs adapting better in China ar
SQQQ TSLA
BDEZ BDEZ 19 minutes ago
TX moves to ban Sharia Law

https://x.com/FarmGirlCarrie/status/1811134301075013781
mikepgator mikepgator 22 minutes ago
Wow nice last minute of trading!
RDGL
Lazarus Lazarus 24 minutes ago
RE: > perhaps...
ooooooh. you dont say?
RJDG
ATLnsider ATLnsider 24 minutes ago
meirluc, I respect your opinion, but I still disagree that there would be any need or added benefit to add SurVaxM to DCVax-L.

DCVax-L already targets survivin, plus hundreds of other antigens, peptides and biomarkers. I will stick with what Dr. Linda Liau and Dr. Robert Prins study r
NWBO
BDEZ BDEZ 26 minutes ago
Welfare costs exploding in Germany

https://x.com/ramzpaul/status/1811041484558283128

Sound familiar?
XMaster2023 XMaster2023 26 minutes ago
Pump, this is small PRE revenue biotech firm. DCVax-L will be their ONLY approved product. What the hell did you expect? Blood from a turnip?
This said approval and revenue are just around the corner. Your boss can shove it!
NWBO
F4Uvet F4Uvet 27 minutes ago
Bravery has nothing to do with the barking dog. The dog was only voicing his opinion regarding the stupidity of the lion's death which was the result of his overwhelming avarice.
MXSG
Tadaaa Tadaaa 32 minutes ago
The enemy does their best work in the Principalities:

-Education
-Politics
-Religion
-Economics
-Propaganda

We war not against flesh and blood but against spiritual wickedness in high places.

Researchfyi Researchfyi 34 minutes ago
Many consumers own smart watches and other smart products used for health related tracking. But, ironically none of them unless used for a specific function like diabetes have FDA approval.

I believe FDA approval for the purposes of sales is a very strategic competitive factor and hug
LQMT
rooster rooster 34 minutes ago
I’m a mechanical contractor who only installs new plumbing and hvac systems
ducci1 ducci1 34 minutes ago
Pivot Calcs: SPX Pivot--5618----R1--5651----R2--5667----R3--5700-----S1--5602----S2--5569----S3--5552 !
SPY

Your Recent History

Delayed Upgrade Clock